Exploratory Clinical Trial of (4 <i>S</i> )-4-(3-[18F]fluoropropyl)- <scp>l</scp> -glutamate for Imaging xC− Transporter Using Positron Emission Tomography in Patients with Non–Small Cell Lung or Breast Cancer
Exploratory Clinical Trial of (4 <i>S</i> )-4-(3-[18F]fluoropropyl)- <scp>l</scp> -glutamate for Imaging xC− Transporter Using Positron Emission Tomography in Patients with Non–Small Cell Lung or Breast Cancer is a paper indexed in PICO Portal from OpenAlex.
How many citations does Exploratory Clinical Trial of (4 <i>S</i> )-4-(3-[18F]fluoropropyl)- <scp>l</scp> -glutamate for Imaging xC− Transporter Using Positron Emission Tomography in Patients with Non–Small Cell Lung or Breast Cancer have?
Exploratory Clinical Trial of (4 <i>S</i> )-4-(3-[18F]fluoropropyl)- <scp>l</scp> -glutamate for Imaging xC− Transporter Using Positron Emission Tomography in Patients with Non–Small Cell Lung or Breast Cancer has 133 citations in the OpenAlex counts PICO Portal stores.
When was Exploratory Clinical Trial of (4 <i>S</i> )-4-(3-[18F]fluoropropyl)- <scp>l</scp> -glutamate for Imaging xC− Transporter Using Positron Emission Tomography in Patients with Non–Small Cell Lung or Breast Cancer published?
Exploratory Clinical Trial of (4 <i>S</i> )-4-(3-[18F]fluoropropyl)- <scp>l</scp> -glutamate for Imaging xC− Transporter Using Positron Emission Tomography in Patients with Non–Small Cell Lung or Breast Cancer has 2012 year in the PICO Portal index.
What is the open-access status of Exploratory Clinical Trial of (4 <i>S</i> )-4-(3-[18F]fluoropropyl)- <scp>l</scp> -glutamate for Imaging xC− Transporter Using Positron Emission Tomography in Patients with Non–Small Cell Lung or Breast Cancer?
Exploratory Clinical Trial of (4 <i>S</i> )-4-(3-[18F]fluoropropyl)- <scp>l</scp> -glutamate for Imaging xC− Transporter Using Positron Emission Tomography in Patients with Non–Small Cell Lung or Breast Cancer has bronze oa status in the PICO Portal index.
What is the DOI of Exploratory Clinical Trial of (4 <i>S</i> )-4-(3-[18F]fluoropropyl)- <scp>l</scp> -glutamate for Imaging xC− Transporter Using Positron Emission Tomography in Patients with Non–Small Cell Lung or Breast Cancer?
The DOI for Exploratory Clinical Trial of (4 <i>S</i> )-4-(3-[18F]fluoropropyl)- <scp>l</scp> -glutamate for Imaging xC− Transporter Using Positron Emission Tomography in Patients with Non–Small Cell Lung or Breast Cancer is on the source record.
What is the PMID of Exploratory Clinical Trial of (4 <i>S</i> )-4-(3-[18F]fluoropropyl)- <scp>l</scp> -glutamate for Imaging xC− Transporter Using Positron Emission Tomography in Patients with Non–Small Cell Lung or Breast Cancer?
The PMID for Exploratory Clinical Trial of (4 <i>S</i> )-4-(3-[18F]fluoropropyl)- <scp>l</scp> -glutamate for Imaging xC− Transporter Using Positron Emission Tomography in Patients with Non–Small Cell Lung or Breast Cancer is on the source record.
What is the OpenAlex record for Exploratory Clinical Trial of (4 <i>S</i> )-4-(3-[18F]fluoropropyl)- <scp>l</scp> -glutamate for Imaging xC− Transporter Using Positron Emission Tomography in Patients with Non–Small Cell Lung or Breast Cancer?
The OpenAlex for Exploratory Clinical Trial of (4 <i>S</i> )-4-(3-[18F]fluoropropyl)- <scp>l</scp> -glutamate for Imaging xC− Transporter Using Positron Emission Tomography in Patients with Non–Small Cell Lung or Breast Cancer is on the source record.